ClinicalTrials.Veeva

Menu

Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities

Yale University logo

Yale University

Status

Terminated

Conditions

Glioblastoma Multiforme

Treatments

Other: dynamic contrast enhanced magnetic resonance imaging

Study type

Observational

Funder types

Other

Identifiers

NCT00589095
0606001531

Details and patient eligibility

About

The purpose of this study is to determine whether dynamic contrast enhanced MRI (DCE MRI) and high diffusion weighting MRI may be used to distinguish between favorable and unfavorable responses to therapy of glioblastoma multiforme. Imaging data will be correlated with histopathologic findings and clinical responses to radiation therapy with or without chemotherapy.

Enrollment

5 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The presence of a primary brain tumor that cannot be completely resected that requires radiation therapy with or without chemotherapy.

Exclusion criteria

  • Patients who do not have a primary brain tumor or who are unable to tolerate the environment of the MRI scanner

Trial design

5 participants in 1 patient group

1
Treatment:
Other: dynamic contrast enhanced magnetic resonance imaging

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems